Ingestible artificial urinary biomarker probes for urine test of gastrointestinal cancer
Although colorectal cancer diagnosed at an early stage shows high curability, methods simultaneously possessing point-of-care testing ability and high sensitivity are limited. Here, an orally deliverable biomarker-activatable probe (termed as HATS) for early detection of orthotopic tumors via remote...
Saved in:
Main Authors: | , , , , , , |
---|---|
Other Authors: | |
Format: | Article |
Language: | English |
Published: |
2024
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/174214 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
id |
sg-ntu-dr.10356-174214 |
---|---|
record_format |
dspace |
spelling |
sg-ntu-dr.10356-1742142024-03-22T15:31:53Z Ingestible artificial urinary biomarker probes for urine test of gastrointestinal cancer Xu, Cheng Xu, Mengke Hu, Yuxuan Liu, Jing Cheng, Penghui Zeng, Ziling Pu, Kanyi School of Chemistry, Chemical Engineering and Biotechnology Lee Kong Chian School of Medicine (LKCMedicine) Medicine, Health and Life Sciences Bioorthogonal reaction Cancer detection Although colorectal cancer diagnosed at an early stage shows high curability, methods simultaneously possessing point-of-care testing ability and high sensitivity are limited. Here, an orally deliverable biomarker-activatable probe (termed as HATS) for early detection of orthotopic tumors via remote urinalysis is presented. To enable its oral delivery to the colon, HATS is designed to have remarkable resistance to acidity and digestive enzymes in the stomach and small intestine and negligible intestinal absorption. Upon reaction with a cancer biomarker in the colon segment, HATS releases a small fragment of tetrazine that can transverse the intestinal barrier, enter blood circulation, and ultimately undergo renal clearance to urine. Subsequently, the urinary tetrazine fragment is detected by bioorthogonal reaction with trans-cyclooctene-caged resorufin (TCO-Reso) to afford a rapid and specific fluorescence enhancement of TCO-Reso. Such signal readout is correlated with the urinary tetrazine concentration and thus measures the level of cancer biomarkers in the colon. HATS-based optical urinalysis detects orthotopic colon tumors two weeks earlier than clinical serological tests and can be developed to a point-of-care paper test. Thereby, HATS-based urinalysis provides a non-invasive and sensitive approach to cancer screening at low-resource settings. Ministry of Education (MOE) National Research Foundation (NRF) Submitted/Accepted version K.P. thanks the Singapore National Research Foundation (NRF) (NRF-NRFI07-2021-0005), and Academic Research Fund Tier 2 (MOE-T2EP30220-0010; MOE-T2EP30221-0004), for the financial support. 2024-03-21T01:44:34Z 2024-03-21T01:44:34Z 2024 Journal Article Xu, C., Xu, M., Hu, Y., Liu, J., Cheng, P., Zeng, Z. & Pu, K. (2024). Ingestible artificial urinary biomarker probes for urine test of gastrointestinal cancer. Advanced Materials. https://dx.doi.org/10.1002/adma.202314084 0935-9648 https://hdl.handle.net/10356/174214 10.1002/adma.202314084 38446383 2-s2.0-85187698423 en NRF-NRFI07-2021-0005 MOE-T2EP30220-0010 MOE‐T2EP30221‐0004 Advanced Materials © 2024 Wiley-VCH GmbH. All rights reserved. This article may be downloaded for personal use only. Any other use requires prior permission of the copyright holder. The Version of Record is available online at http://doi.org/10.1002/adma.202314084. application/pdf |
institution |
Nanyang Technological University |
building |
NTU Library |
continent |
Asia |
country |
Singapore Singapore |
content_provider |
NTU Library |
collection |
DR-NTU |
language |
English |
topic |
Medicine, Health and Life Sciences Bioorthogonal reaction Cancer detection |
spellingShingle |
Medicine, Health and Life Sciences Bioorthogonal reaction Cancer detection Xu, Cheng Xu, Mengke Hu, Yuxuan Liu, Jing Cheng, Penghui Zeng, Ziling Pu, Kanyi Ingestible artificial urinary biomarker probes for urine test of gastrointestinal cancer |
description |
Although colorectal cancer diagnosed at an early stage shows high curability, methods simultaneously possessing point-of-care testing ability and high sensitivity are limited. Here, an orally deliverable biomarker-activatable probe (termed as HATS) for early detection of orthotopic tumors via remote urinalysis is presented. To enable its oral delivery to the colon, HATS is designed to have remarkable resistance to acidity and digestive enzymes in the stomach and small intestine and negligible intestinal absorption. Upon reaction with a cancer biomarker in the colon segment, HATS releases a small fragment of tetrazine that can transverse the intestinal barrier, enter blood circulation, and ultimately undergo renal clearance to urine. Subsequently, the urinary tetrazine fragment is detected by bioorthogonal reaction with trans-cyclooctene-caged resorufin (TCO-Reso) to afford a rapid and specific fluorescence enhancement of TCO-Reso. Such signal readout is correlated with the urinary tetrazine concentration and thus measures the level of cancer biomarkers in the colon. HATS-based optical urinalysis detects orthotopic colon tumors two weeks earlier than clinical serological tests and can be developed to a point-of-care paper test. Thereby, HATS-based urinalysis provides a non-invasive and sensitive approach to cancer screening at low-resource settings. |
author2 |
School of Chemistry, Chemical Engineering and Biotechnology |
author_facet |
School of Chemistry, Chemical Engineering and Biotechnology Xu, Cheng Xu, Mengke Hu, Yuxuan Liu, Jing Cheng, Penghui Zeng, Ziling Pu, Kanyi |
format |
Article |
author |
Xu, Cheng Xu, Mengke Hu, Yuxuan Liu, Jing Cheng, Penghui Zeng, Ziling Pu, Kanyi |
author_sort |
Xu, Cheng |
title |
Ingestible artificial urinary biomarker probes for urine test of gastrointestinal cancer |
title_short |
Ingestible artificial urinary biomarker probes for urine test of gastrointestinal cancer |
title_full |
Ingestible artificial urinary biomarker probes for urine test of gastrointestinal cancer |
title_fullStr |
Ingestible artificial urinary biomarker probes for urine test of gastrointestinal cancer |
title_full_unstemmed |
Ingestible artificial urinary biomarker probes for urine test of gastrointestinal cancer |
title_sort |
ingestible artificial urinary biomarker probes for urine test of gastrointestinal cancer |
publishDate |
2024 |
url |
https://hdl.handle.net/10356/174214 |
_version_ |
1794549493267431424 |